Evidence map›Paper›PMID 39135028›Full record

ReviewBMC medical genomics2024

A novel variant in the SPTB gene underlying hereditary spherocytosis and a literature review of previous variants.

Yang Wang, Tao Liu, Chenxi Jia, Li Xiao, Wen Wang, Yongjie Zhang, Yan Xiang, Lan Huang, Jie Yu

Abstract readCase ReportsReview
In one paragraph

Review in BMC medical genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. A novelFrontiers in pediatrics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang Wang *Department of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Tao Liu *Department of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Chenxi JiaChongqing Key Laboratory of Structural Birth Defect and Reconstruction, Chongqing, China.
Li XiaoDepartment of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Wen WangShanghai University of Medicine & Health Sciences, Shanghai, China.
Yongjie ZhangDepartment of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Yan XiangDepartment of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Lan HuangDepartment of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China.
Jie YuDepartment of Hematology and Oncology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolismand Inflammatory Diseases, Children's Hospital of Chongqing Medical University, 136 Zhongshanerlu, Yu Zhong district, Chongqing, 400014, China. yujie@hospital.cqmu.edu.cn.

Funding

Public Welfare Project for Rare Blood Disorders in the field of Hematology in China xyxthjb-2023-006
6 · The paper itself

Abstract

backgroundHereditary spherocytosis (HS, MIM#612641) is one of the most common hereditary hemolytic disorders. This study aimed to confirm a novel variant's pathogenicity and reveal a patient's genetic etiology.

methodsThe clinical data of a patient with HS who underwent genetic sequencing at the Children's Hospital of Chongqing Medical University were reviewed retrospectively. In silico prediction and in vitro minigene splicing reporter system were then conducted on the detected variant to analyze its intramolecular impact. A summary of the literature related to HS due to SPTB gene variants was also presented.

resultsA novel variant (c.301-2 A > G) in the SPTB gene (NM_001024858.4) was identified in the proband. Using Sanger sequencing, we conclusively confirmed that the inheritance of the variant could not be traced to the biological parents. The in vitro minigene assay revealed three different transcripts derived from the c.301-2 A > G variant: r.301_474del, r.301_306delCCAAAG, and r.301-1_301-57ins. Through a literature review, patients with HS who had been genotypically validated were summarized and the SPTB gene variant profile was mapped.

conclusionWe identified a splicing variant of the SPTB gene, thus confirming its aberrant translation. The novel variant was the probable genetic etiology of the proband with HS. Our findings expanded the variant spectrum of the SPTB gene, thus improving the understanding of the associated hereditary hemolytic disorders from a clinical and molecular perspective and contributing to the foundation of genetic counseling and diagnosis.

Indexed as

SpectrinSpherocytosis, HereditaryFemaleHumansMaleMutationPedigreeRNA SplicingSpectrinSPTB protein, humanHereditary spherocytosisMinigeneNovel variantSPTB gene

Identifiers

PMID39135028
PMCPMC11318180

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.